Clinical trials for biosimilars

Clinical trials for biosimilars are research studies designed to evaluate new products that are highly similar to existing biologic medications. These trials assess the safety, efficacy, and quality of the biosimilar compared to the original drug. In these studies, researchers check how the biosimilar behaves in the body and whether it produces the same therapeutic effects. By demonstrating similarity, biosimilars can gain regulatory approval, offering potentially lower-cost alternatives to patients while maintaining the treatment benefits of the original biologic. The process ensures that biosimilars are as safe and effective as their reference products.